Liisa Ann Bayko insider trades
Open-market stock purchases and sales by Liisa Ann Bayko, Chief Financial Officer at Kalaris Therapeutics, Inc, from SEC Form 4 filings since Jul 20, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 20, 2026 | KLRS Kalaris Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- KLRS Kalaris Therapeutics, Inc: other filings, last Jul 20, 2026